Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EpilepsyConnect is a specialized digital health platform and service dedicated to connecting patients with epilepsy to relevant clinical trials. Operating as a service of Antidote Technologies, the platform utilizes advanced search technology and patient-centric design to simplify the process of finding and enrolling in medical research. It provides a comprehensive database of ongoing epilepsy studies, offering tools for patients to determine their eligibility and connect directly with research sites. By bridging the gap between the epilepsy community and the pharmaceutical industry, EpilepsyConnect aims to accelerate the development of new treatments and improve patient access to innovative care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Epilepsy Connect.